Skip to main content
Top
Published in: Calcified Tissue International 6/2019

01-12-2019 | Sarcopenia | Original Research

Functional Measures of Sarcopenia: Prevalence, and Associations with Functional Disability in 10,892 Adults Aged 65 Years and Over from Six Lower- and Middle-Income Countries

Authors: Sharon L. Brennan-Olsen, Steven J. Bowe, Paul Kowal, Nirmala Naidoo, Nekehia T. Quashie, Geeta Eick, Sutapa Agrawal, Catherine D’Este

Published in: Calcified Tissue International | Issue 6/2019

Login to get access

Abstract

Identification of sarcopenia in lower- and middle-income countries (LMICs) is limited by access to technologies that assess muscle mass. We investigated associations between two functional measures of sarcopenia, grip strength and gait speed (GS), with functional disability in adults from six LMICs. Data were extracted from the World Health Organization (WHO) Study on global AGEing and adult health Wave 1 (2007–2010) for adults (≥ 65 years) from China, Mexico, Ghana, India, Russia and South Africa (n = 10,892, 52.8% women). We calculated country-specific prevalence of low grip strength, slow GS (≤ 0.8 m/s), and both measures combined. Using multivariable negative binomial regression, we separately assessed associations between low grip strength, slow GS, and both measures combined, with the WHO Disability Assessment Schedule 2.0, accounting for selected socioeconomic factors. In women, low grip strength ranged from 7 in South Africa to 51% in India; in men, it ranged from 17 in Russia to 51% in Mexico. Country-specific proportions of slow GS ranged from 77 in Russia, to 33% in China. The concomitant presence of both was the lowest in South Africa and the highest in India (12.3% vs. 33%). Independent of age, those with both low grip strength and slow GS had between 1.2- and 1.5-fold worse functional disability scores, independent of comorbidities, low education, and low wealth (all country-dependent). Low grip strength, slow GS, and the combination of both, were all associated with higher levels of functional disability, thus indicating these objective measures offer a reasonably robust estimate for potential poor health outcomes.
Appendix
Available only for authorised users
Literature
1.
go back to reference Scott D, de Courten B, Ebeling PR (2016) Sarcopenia: a potential cause and consequence of type 2 diabetes in Australia’s ageing population? Med J Aust 205:329–333CrossRef Scott D, de Courten B, Ebeling PR (2016) Sarcopenia: a potential cause and consequence of type 2 diabetes in Australia’s ageing population? Med J Aust 205:329–333CrossRef
2.
go back to reference Narici MV, Mafulli N (2010) Sarcopenia: characteristics, mechanisms and functional significance. Br Med Bull 95:139–159CrossRef Narici MV, Mafulli N (2010) Sarcopenia: characteristics, mechanisms and functional significance. Br Med Bull 95:139–159CrossRef
3.
go back to reference Miljkovic N, Lim J-Y, Miljkovic I, Frontera WR (2015) Aging of skeletal muscle fibers. Ann Rehabil Med 39:155–162CrossRef Miljkovic N, Lim J-Y, Miljkovic I, Frontera WR (2015) Aging of skeletal muscle fibers. Ann Rehabil Med 39:155–162CrossRef
4.
go back to reference Schaap LA, van Schoor NM, Lips P, Visser M (2018) Associations of sarcopenia definitions, and their components, with the incidence of recurrent falling and fractures: the Longitudinal Aging Study Amsterdan. J Gerontol 73:1199–1204CrossRef Schaap LA, van Schoor NM, Lips P, Visser M (2018) Associations of sarcopenia definitions, and their components, with the incidence of recurrent falling and fractures: the Longitudinal Aging Study Amsterdan. J Gerontol 73:1199–1204CrossRef
5.
go back to reference Mijnarends DM, Schols JMGA, Halfens RJG, Meijers JMM, Luiking YC, Verlaan S, Evers SMAA (2016) Burden-of-illness of Dutch community-dwelling older adults with sarcopenia: health related outcomes and costs. Eur Geriatr Med 7:276–284CrossRef Mijnarends DM, Schols JMGA, Halfens RJG, Meijers JMM, Luiking YC, Verlaan S, Evers SMAA (2016) Burden-of-illness of Dutch community-dwelling older adults with sarcopenia: health related outcomes and costs. Eur Geriatr Med 7:276–284CrossRef
6.
go back to reference Reijnierse EM, Trappenburg MC, Leter MH, Blauw GJ, Sipila S, Sillanpaa E, Narici MV, Hogrel JY, Butler-Browne G, McPhee JS, Gapeyeva H, Paasuke M, de van der Schueren MA, Meskers CG, Maier AB (2015) The impact of different diagnostic criteria on the prevalence of sarcopenia in healthy elderly participants and geriatric outpatients. Gerontology 61:491–496CrossRef Reijnierse EM, Trappenburg MC, Leter MH, Blauw GJ, Sipila S, Sillanpaa E, Narici MV, Hogrel JY, Butler-Browne G, McPhee JS, Gapeyeva H, Paasuke M, de van der Schueren MA, Meskers CG, Maier AB (2015) The impact of different diagnostic criteria on the prevalence of sarcopenia in healthy elderly participants and geriatric outpatients. Gerontology 61:491–496CrossRef
7.
go back to reference Volpato S, Bianchi L, Cherubini A, Landi F, Maggio M, Savino E, Bandinelli S, Ceda GP, Guralnik JM, Zuliani G, Ferrucci L (2014) Prevalence and clinical correlates of sarcopenia in community-dwelling older people: application of the EWGSOP definition and diagnostic algorithm. J Gerontol Ser A 69:438–446CrossRef Volpato S, Bianchi L, Cherubini A, Landi F, Maggio M, Savino E, Bandinelli S, Ceda GP, Guralnik JM, Zuliani G, Ferrucci L (2014) Prevalence and clinical correlates of sarcopenia in community-dwelling older people: application of the EWGSOP definition and diagnostic algorithm. J Gerontol Ser A 69:438–446CrossRef
8.
go back to reference Beaudart C, Rizzoli R, Bruyere O, Reginster J-Y, Biver E (2014) Sarcopenia: burden and challenges for public health. Arch Public Health 72:45CrossRef Beaudart C, Rizzoli R, Bruyere O, Reginster J-Y, Biver E (2014) Sarcopenia: burden and challenges for public health. Arch Public Health 72:45CrossRef
9.
go back to reference Landi F, Liperoti R, Russo A et al (2012) Sarcopenia as a risk factor for falls in elderly individuals: results from the ilSIRENTE study. Clin Nutr 31:652–658CrossRef Landi F, Liperoti R, Russo A et al (2012) Sarcopenia as a risk factor for falls in elderly individuals: results from the ilSIRENTE study. Clin Nutr 31:652–658CrossRef
10.
go back to reference Clark BC, Manini TM (2008) Sarcopenia dynapenia. J Gerontol Ser A 63:829–834CrossRef Clark BC, Manini TM (2008) Sarcopenia dynapenia. J Gerontol Ser A 63:829–834CrossRef
11.
go back to reference Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, Schneider SM, Sieber CC, Topinkova E, Vandewoude M, Visser M, Zamboni M, Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2 (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48:16–31CrossRef Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, Schneider SM, Sieber CC, Topinkova E, Vandewoude M, Visser M, Zamboni M, Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2 (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48:16–31CrossRef
12.
go back to reference Chen LK, Liu LK, Woo J, Assantachai P, Auyeung TW, Bahyah KS, Chou MY, Chen LY, Hsu PS, Krairit O, Lee JS, Lee Y, Liang CK, Limpawattana P, Lin CS, Peng LN, Satake S, Suzuki T, Won CH, Wu SN, Zhang T, Zeng P, Akishita M, Aria H (2014) Sarcopenia in Asia: consensus report of the Asian Working Group for sarcopenia. J Am Med Dir Assoc 15:95–101CrossRef Chen LK, Liu LK, Woo J, Assantachai P, Auyeung TW, Bahyah KS, Chou MY, Chen LY, Hsu PS, Krairit O, Lee JS, Lee Y, Liang CK, Limpawattana P, Lin CS, Peng LN, Satake S, Suzuki T, Won CH, Wu SN, Zhang T, Zeng P, Akishita M, Aria H (2014) Sarcopenia in Asia: consensus report of the Asian Working Group for sarcopenia. J Am Med Dir Assoc 15:95–101CrossRef
13.
go back to reference Stringhini S, Carmeli C, Jokela M, Avendano M, McCrory C, d’Errico A, Bochud M, Barros H, Cost G, Chadeau-Hyam M, Delpierre C, Gandini M, Fraga S, Goldberg M, Giles GG, Lassale C, Kenny RA, Kelly-Irving M, Paccaud F, Layte R, Muennig P, Marmot MG, Ribeiro AI, Severi G, Steptoe A, Shipley MJ, Zins M, Mackenbach JP, Vineis P, Kivimaki M, for the LIFEPATH Consortium (2018) Socioeconomic status, non-communicable disease risk factors, and walking speed in older adults: multi-cohort population based study. BMJ 360:k1046CrossRef Stringhini S, Carmeli C, Jokela M, Avendano M, McCrory C, d’Errico A, Bochud M, Barros H, Cost G, Chadeau-Hyam M, Delpierre C, Gandini M, Fraga S, Goldberg M, Giles GG, Lassale C, Kenny RA, Kelly-Irving M, Paccaud F, Layte R, Muennig P, Marmot MG, Ribeiro AI, Severi G, Steptoe A, Shipley MJ, Zins M, Mackenbach JP, Vineis P, Kivimaki M, for the LIFEPATH Consortium (2018) Socioeconomic status, non-communicable disease risk factors, and walking speed in older adults: multi-cohort population based study. BMJ 360:k1046CrossRef
14.
go back to reference Ramlagan S, Peltzer K, Phaswana-Mafuya N (2014) Hand grip strength and associated factors in non-institutionalised men and women 50 years and older in South Africa. BMC Res Notes 7:8CrossRef Ramlagan S, Peltzer K, Phaswana-Mafuya N (2014) Hand grip strength and associated factors in non-institutionalised men and women 50 years and older in South Africa. BMC Res Notes 7:8CrossRef
15.
go back to reference Kowal P, Chatterji S, Naidoo N, Biritwum R, Fan W, Ridaura RL, Maximova T, Arokiasamy P, Phaswana-Mafuya N, Williams S, Snodgrass JJ, Minicuci N, E’Este C, Peltzer K, Boerma JT, the SAGE collaborators (2012) Data resource profile: the World Health Organization Study on global AGEing and adult health (SAGE). Int J Epidemiol 41:1639–1649CrossRef Kowal P, Chatterji S, Naidoo N, Biritwum R, Fan W, Ridaura RL, Maximova T, Arokiasamy P, Phaswana-Mafuya N, Williams S, Snodgrass JJ, Minicuci N, E’Este C, Peltzer K, Boerma JT, the SAGE collaborators (2012) Data resource profile: the World Health Organization Study on global AGEing and adult health (SAGE). Int J Epidemiol 41:1639–1649CrossRef
16.
go back to reference Chatterji S (2013) World Health Organization’s (WHO) Study global AGEing and adult health (SAGE). BMC Proc 7:S1CrossRef Chatterji S (2013) World Health Organization’s (WHO) Study global AGEing and adult health (SAGE). BMC Proc 7:S1CrossRef
18.
go back to reference World Health Organization (2010) Measuring health and disability: manual for WHO disability assessment schedule (WHODAS 2.0). In: Ustun TB, Kostanjsek N, Chatterji S, Rehm J (ed). WHO, Geneva World Health Organization (2010) Measuring health and disability: manual for WHO disability assessment schedule (WHODAS 2.0). In: Ustun TB, Kostanjsek N, Chatterji S, Rehm J (ed). WHO, Geneva
20.
go back to reference World Health Organization (2000) The Asia-Pacific perspective: redefining obesity and its treatment. WHO Western Pacific Region, Geneva World Health Organization (2000) The Asia-Pacific perspective: redefining obesity and its treatment. WHO Western Pacific Region, Geneva
21.
go back to reference Brennan-Olsen SLSS, Viikari-Juntura E, Ackerman IN, Bowe SJ, Kowal P, Naidoo N, Chatterji S, Wluka AE, Leech MT, Page RS, Sanders KM, Gomez F, Duque G, Green D, Mohebbi M (2018) Arthritis diagnosis and symptoms are positively associated with specific physical job exposures in lower- and middle-income countries: cross-sectional results from the World Health Organization’s Study on global AGEing and adult helath (SAGE). BMC Public Health 8:1 Brennan-Olsen SLSS, Viikari-Juntura E, Ackerman IN, Bowe SJ, Kowal P, Naidoo N, Chatterji S, Wluka AE, Leech MT, Page RS, Sanders KM, Gomez F, Duque G, Green D, Mohebbi M (2018) Arthritis diagnosis and symptoms are positively associated with specific physical job exposures in lower- and middle-income countries: cross-sectional results from the World Health Organization’s Study on global AGEing and adult helath (SAGE). BMC Public Health 8:1
22.
go back to reference Cleland CLHR, Kee F, Cupples ME, Sallis JF, Tully MA (2014) Validity of the Global Physical Activity Questionnaire (GPAQ) in assessing levels and change in moderate-vigorous physical activity and sedentary behaviour. BMC Public Health 14:1255CrossRef Cleland CLHR, Kee F, Cupples ME, Sallis JF, Tully MA (2014) Validity of the Global Physical Activity Questionnaire (GPAQ) in assessing levels and change in moderate-vigorous physical activity and sedentary behaviour. BMC Public Health 14:1255CrossRef
23.
go back to reference Gaskin CJ, Orellana L (2018) Factors associated with physical activity and sedentary behaviour in older adults from six low- and middle-income countries. Int J Environ Res Public Health 15:908CrossRef Gaskin CJ, Orellana L (2018) Factors associated with physical activity and sedentary behaviour in older adults from six low- and middle-income countries. Int J Environ Res Public Health 15:908CrossRef
24.
go back to reference Bull FC, Maslin TS, Armstrong T (2009) Global Physical Activity Questionnaire (GPAQ): nine country reliability and validity study. J Phys Act Health 6:790–804CrossRef Bull FC, Maslin TS, Armstrong T (2009) Global Physical Activity Questionnaire (GPAQ): nine country reliability and validity study. J Phys Act Health 6:790–804CrossRef
25.
go back to reference Herrmann SD, Heumann KJ, Der Ananian CA, Ainsworth BE (2013) Validity and reliability of the Global Physical Activity Questionnaire (GPAQ). Meas Phys Educ Exerc Sci 17:221–235CrossRef Herrmann SD, Heumann KJ, Der Ananian CA, Ainsworth BE (2013) Validity and reliability of the Global Physical Activity Questionnaire (GPAQ). Meas Phys Educ Exerc Sci 17:221–235CrossRef
26.
go back to reference Chu AHY, Ng SHX, Koh D, Muller-Riemenschneider F (2015) Reliability and validity of the self- and interviewer-administered versions of the Global Physical Activity Questionnaire (GPAQ). PLoS ONE 10:e0136944CrossRef Chu AHY, Ng SHX, Koh D, Muller-Riemenschneider F (2015) Reliability and validity of the self- and interviewer-administered versions of the Global Physical Activity Questionnaire (GPAQ). PLoS ONE 10:e0136944CrossRef
27.
go back to reference World Health Organization (2010) Global recommendations on physical activity for health. WHO, Geneva World Health Organization (2010) Global recommendations on physical activity for health. WHO, Geneva
28.
go back to reference Gunasekaran V, Banerjee J, Dwivedi SN, Upadhyay AD, Chatterjee P, Dey AB (2016) Normal gait speed, grip strength and thirty seconds chair stand test among older Indians. Arch Gerontol Geriatr 67:171–178CrossRef Gunasekaran V, Banerjee J, Dwivedi SN, Upadhyay AD, Chatterjee P, Dey AB (2016) Normal gait speed, grip strength and thirty seconds chair stand test among older Indians. Arch Gerontol Geriatr 67:171–178CrossRef
29.
go back to reference Zeng P, Wu S, Han Y, Liu J, Zhang Y, Zhang E, Zhang Y, Gong H, Pang J, Tang Z, Liu H, Zheng X, Zhang T (2015) Differences in body composition and physical functions associated with sarcopenia in Chinese elderly: reference values and prevalence. Arch Gerontol Geriatr 60:118–123CrossRef Zeng P, Wu S, Han Y, Liu J, Zhang Y, Zhang E, Zhang Y, Gong H, Pang J, Tang Z, Liu H, Zheng X, Zhang T (2015) Differences in body composition and physical functions associated with sarcopenia in Chinese elderly: reference values and prevalence. Arch Gerontol Geriatr 60:118–123CrossRef
30.
go back to reference Bohannon RW (2015) Muscle strength: clinical and prognostic value of hand-grip dynamometry. Curr Opin Clin Nutr Metab Care 18:465–470CrossRef Bohannon RW (2015) Muscle strength: clinical and prognostic value of hand-grip dynamometry. Curr Opin Clin Nutr Metab Care 18:465–470CrossRef
31.
go back to reference Alley DE, Shardell MD, Peters KW, McLean RR, Dam T-TL, Kenny AM, Fragala MS, Harris TB, Kiel DP, Guralnik JM, Ferrucci L, Kritchevsky SB, Studenski SA, Vassileva MT, Cawthon PM (2014) Grip strength cutpoints for the identification of clinically relevant weakness. J Gerontol Ser A 69:559–566CrossRef Alley DE, Shardell MD, Peters KW, McLean RR, Dam T-TL, Kenny AM, Fragala MS, Harris TB, Kiel DP, Guralnik JM, Ferrucci L, Kritchevsky SB, Studenski SA, Vassileva MT, Cawthon PM (2014) Grip strength cutpoints for the identification of clinically relevant weakness. J Gerontol Ser A 69:559–566CrossRef
32.
go back to reference Ibrahim K, May C, Patel HP, Baxter M, Sayer AA, Roberts H (2016) A feasibility study of implementing grip strength measurement into routine hospital practice (GRImP): study protocol. Pilot Feasibility Study 2:27CrossRef Ibrahim K, May C, Patel HP, Baxter M, Sayer AA, Roberts H (2016) A feasibility study of implementing grip strength measurement into routine hospital practice (GRImP): study protocol. Pilot Feasibility Study 2:27CrossRef
33.
go back to reference Cesari M, Kritchevsky SB, Newman AB, Simonsick EM, Harris TB, Penninx BW, Brach JS, Tylavsky FA, Satterfield S, Bauer DC, Rubin SM, Visser M, Pahor M, for the Health ABC Study (2009) Added value of physical performance measures in predicting adverse health-related events: results from the Health, Aging, and Body Composition Study. J Am Geriatr Soc 57:251–259CrossRef Cesari M, Kritchevsky SB, Newman AB, Simonsick EM, Harris TB, Penninx BW, Brach JS, Tylavsky FA, Satterfield S, Bauer DC, Rubin SM, Visser M, Pahor M, for the Health ABC Study (2009) Added value of physical performance measures in predicting adverse health-related events: results from the Health, Aging, and Body Composition Study. J Am Geriatr Soc 57:251–259CrossRef
34.
go back to reference Castell M-V, Sanchez M, Julian R, Queipo R, Martin S, Otero A (2013) Frailty prevalence and slow walking speed in persons age 65 and older: implications for primary care. BMC Family Pract 14:86CrossRef Castell M-V, Sanchez M, Julian R, Queipo R, Martin S, Otero A (2013) Frailty prevalence and slow walking speed in persons age 65 and older: implications for primary care. BMC Family Pract 14:86CrossRef
35.
go back to reference Hoy D, Geere JA, Davatchi F, Meggitt B, Barrero LH (2014) A time for action: opportunities for preventing the growing burden and disability from musucloskeletal conditions in low- and middle-income countries. Best Pract Res Clin Rheumatol 28:377–393CrossRef Hoy D, Geere JA, Davatchi F, Meggitt B, Barrero LH (2014) A time for action: opportunities for preventing the growing burden and disability from musucloskeletal conditions in low- and middle-income countries. Best Pract Res Clin Rheumatol 28:377–393CrossRef
36.
go back to reference World Health Organization (2015) Health and human rights. In: WHO (ed) Geneva World Health Organization (2015) Health and human rights. In: WHO (ed) Geneva
37.
go back to reference Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA (2001) Frailty in older adults: evidence for a phenotype. J Gerontol 56:M146–M157CrossRef Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA (2001) Frailty in older adults: evidence for a phenotype. J Gerontol 56:M146–M157CrossRef
Metadata
Title
Functional Measures of Sarcopenia: Prevalence, and Associations with Functional Disability in 10,892 Adults Aged 65 Years and Over from Six Lower- and Middle-Income Countries
Authors
Sharon L. Brennan-Olsen
Steven J. Bowe
Paul Kowal
Nirmala Naidoo
Nekehia T. Quashie
Geeta Eick
Sutapa Agrawal
Catherine D’Este
Publication date
01-12-2019
Publisher
Springer US
Keyword
Sarcopenia
Published in
Calcified Tissue International / Issue 6/2019
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-019-00609-x

Other articles of this Issue 6/2019

Calcified Tissue International 6/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.